ANGELA CLABORN: Open Payments
NPI 1558719989 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 25 payments from 12 companies in 2025. Trend: 2023 $551 · 2024 $1,535 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| PROTEGA PHARMACEUTIALS INC | 2 | $196 |
| Forte Bio-Pharma LLC | 9 | $144 |
| Globus Medical, Inc. | 1 | $96 |
| ABBVIE INC. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| BIOTRONIK NRO, Inc. | 2 | $36 |
| SI-BONE, INC. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Tonix Medicines, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: ROXYBOND, PROLATE, Senza, RELISTOR, Prospera, UBRELVY, JOURNAVX, TONMYA.
Industry payments across NE — which companies pay providers there.
